The Liquid Silhouette: How AlloClae Is Expanding Non-Surgical Body Sculpting in New York
Body sculpting in New York has historically split into two pretty distinct camps, with very different patient experiences and outcomes. Surgical options, including liposuction and autologous fat grafting, involve downtime, anesthesia, and the harvest-and-transfer logistics defining those procedures. Non-surgical options mostly address superficial concerns without genuinely changing the underlying structural contour. AlloClae arrived in the New York market in 2025 and, through 2026, as a third option, filling the gap between those camps, with LUXURGERY in NYC building specialized protocols for patients seeking real contour change without the surgical commitment.
Anyone searching for NYC liposuction options across the city is usually weighing surgical recovery against the limits of non-surgical alternatives, and the AlloClae category specifically addresses patients caught in the middle of that call. Sachin M. Shridharani, MD, FACS: LUXURGERY built the AlloClae NYC protocol around the specific patient population that genuinely needs volume restoration or contour refinement without undergoing surgery. Structural adipose tissue is obtained from screened donor sources rather than from the patient’s own body, thereby eliminating the need for donor-site surgery. Subtle volume enhancement and contour correction across body areas where small structural changes yield meaningful aesthetic outcomes. Treatment is delivered through in-office injection protocols rather than operating room procedures, meaning patients get back to normal activities substantially faster than surgical recovery actually allows.
“AlloClae sits in a genuinely distinct clinical category from what patients have historically had access to,” Dr. Sachin M. Shridharani said. “We had a patient last quarter, late thirties, who wanted refined contour correction on her hips and lateral thighs but was firmly opposed to surgical liposuction or traditional fat grafting because of the downtime and donor-site recovery either approach requires. She also wasn’t interested in injectable filler categories that wouldn’t deliver structural change. AlloClae enabled us to address her specific contour goals in the office over two treatment sessions with minimal downtime. Three months later, her results are subtle, structural, and entirely consistent with what she was looking for. That outcome simply wasn’t available through any other category until recently.”
The AlloClae protocols at LUXURGERY focus on several specific clinical considerations centered on appropriate patient selection and treatment planning, rather than positioning the product as universally applicable. Patient assessment to determine whether AlloClae fits the clinical picture better than autologous fat grafting, surgical liposuction, traditional dermal fillers, or other body-contouring options already available. Treatment area mapping covering specific anatomical zones where AlloClae produces predictable, refined outcomes, including hip dips, lateral thigh contour, post-surgical contour irregularities, and similar refined-volume applications. Multi-session planning across appropriate treatment intervals, since some patients require staged sessions rather than a single-treatment correction, depending on individual contour goals. Follow-up assessment is built into the protocol because structural volume changes evolve over the months following injection rather than presenting fully on the day of the procedure.
About Sachin M. Shridharani, MD, FACS: LUXURGERY
LUXURGERY runs a board-certified plastic surgery practice in New York City, led by Dr. Sachin M. Shridharani, serving patients across Manhattan and the wider New York metro region, as well as those traveling from across the United States and internationally for specialized aesthetic care. The practice covers surgical body contouring, including liposuction and autologous fat grafting; AlloClae structural adipose tissue treatments; breast and body procedures; facial aesthetic surgery; non-surgical aesthetic protocols; and individualized treatment planning across the full aesthetic continuum. Every consultation includes a thorough clinical assessment, a realistic discussion of outcomes, and the evidence-based treatment planning expected in board-certified plastic surgery practice.
Media Contact
Company Name: Luxurgery
Address:880 5th Ave Suite 1A/B/C/D
City: New York
State: NY 10021
Country: United States
Website: https://www.Luxurgerynyc.com/
